Invivyd [IVVD] vs Tonix [TNXP] Detailed Stock Comparison
Invivyd
NASDAQ
Loading...
Tonix
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Invivyd wins in 6 metrics, Tonix wins in 12 metrics, with 0 ties. Tonix appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Invivyd | Tonix | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.80 | 0.01 | Invivyd |
| Price-to-Book Ratio | 3.20 | 1.19 | Tonix |
| Debt-to-Equity Ratio | 6.93 | 0.29 | Tonix |
| PEG Ratio | 0.01 | 0.00 | Tonix |
| EV/EBITDA | -0.94 | -1.35 | Tonix |
| Profit Margin (TTM) | -238.33% | 23.07% | Tonix |
| Operating Margin (TTM) | -127.78% | -1,416.22% | Invivyd |
| Return on Equity | -120.08% | -77.51% | Tonix |
| Return on Assets (TTM) | -53.25% | -39.97% | Tonix |
| Free Cash Flow (TTM) | $-170.63M | $-61.05M | Tonix |
| 1-Year Return | 40.74% | 76.93% | Tonix |
| Price-to-Sales Ratio (TTM) | 5.17 | 23.66 | Invivyd |
| Enterprise Value | $105.02M | $107.81M | Tonix |
| EV/Revenue Ratio | 2.27 | 10.97 | Invivyd |
| Gross Profit Margin (TTM) | 94.19% | -63.76% | Invivyd |
| Revenue per Share (TTM) | $0 | $2 | Tonix |
| Earnings per Share (Diluted) | $-0.92 | $2,537.00 | Tonix |
| Beta (Stock Volatility) | 0.55 | 1.87 | Invivyd |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Invivyd vs Tonix Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Invivyd | 1.32% | 17.53% | 58.33% | 22.58% | 7.55% | 137.50% |
| Tonix | -4.90% | -10.43% | -44.36% | -30.90% | 142.15% | -15.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Invivyd | 40.74% | -75.22% | -94.54% | -94.54% | -94.54% | -94.54% |
| Tonix | 76.93% | 76.93% | 76.93% | 76.93% | 76.93% | 76.93% |
Performance & Financial Health Analysis: Invivyd vs Tonix
| Metric | IVVD | TNXP |
|---|---|---|
| Market Information | ||
| Market Cap | $238.69M | $241.91M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 26,090,460 | 1,068,119 |
| 90 Day Avg. Volume | 9,430,330 | 1,840,761 |
| Last Close | $1.15 | $25.24 |
| 52 Week Range | $0.35 - $2.74 | $6.76 - $130.00 |
| % from 52W High | -57.85% | -80.58% |
| All-Time High | $78.82 (Nov 29, 2021) | $69.97 (Aug 14, 2025) |
| % from All-Time High | -98.54% | -63.93% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 4.21% | -0.10% |
| Quarterly Earnings Growth | 4.21% | -0.10% |
| Financial Health | ||
| Profit Margin (TTM) | -2.38% | 0.23% |
| Operating Margin (TTM) | -1.28% | -14.16% |
| Return on Equity (TTM) | -1.20% | -0.78% |
| Debt to Equity (MRQ) | 6.93 | 0.29 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.36 | $22.26 |
| Cash per Share (MRQ) | $0.29 | $14.30 |
| Operating Cash Flow (TTM) | $-113,108,000 | $-64,843,000 |
| Levered Free Cash Flow (TTM) | $-47,749,248 | $-42,446,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Invivyd vs Tonix
| Metric | IVVD | TNXP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.80 | 0.01 |
| Forward P/E | -5.70 | -0.86 |
| PEG Ratio | 0.01 | 0.00 |
| Price to Sales (TTM) | 5.17 | 23.66 |
| Price to Book (MRQ) | 3.20 | 1.19 |
| Market Capitalization | ||
| Market Capitalization | $238.69M | $241.91M |
| Enterprise Value | $105.02M | $107.81M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.27 | 10.97 |
| Enterprise to EBITDA | -0.94 | -1.35 |
| Risk & Other Metrics | ||
| Beta | 0.55 | 1.87 |
| Book Value per Share (MRQ) | $0.36 | $22.26 |
Financial Statements Comparison: Invivyd vs Tonix
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IVVD | TNXP |
|---|---|---|
| Revenue/Sales | $11.79M | $2.43M |
| Cost of Goods Sold | $685,000 | $943,000 |
| Gross Profit | $11.10M | $1.49M |
| Research & Development | $9.57M | $7.44M |
| Operating Income (EBIT) | $-15.06M | $-15.13M |
| EBITDA | $-14.56M | $-12.55M |
| Pre-Tax Income | $-14.66M | $-16.83M |
| Income Tax | N/A | N/A |
| Net Income (Profit) | $-14.66M | $-16.83M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IVVD | TNXP |
|---|---|---|
| Cash & Equivalents | $48.08M | $131.72M |
| Total Current Assets | $75.83M | $149.57M |
| Total Current Liabilities | $49.60M | $12.15M |
| Long-Term Debt | N/A | $328,000 |
| Total Shareholders Equity | $54.15M | $180.40M |
| Retained Earnings | $-918.28M | $-747.52M |
| Property, Plant & Equipment | $2.48M | $12.63M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IVVD | TNXP |
|---|---|---|
| Operating Cash Flow | $-12.47M | $-15.10M |
| Capital Expenditures | $-144,000 | $-6,000 |
| Free Cash Flow | $-21.27M | $-16.59M |
| Debt Repayment | N/A | $-9.65M |
| Common Stock Repurchase | N/A | $-3.05M |
Short Interest & Institutional Ownership Analysis
| Metric | IVVD | TNXP |
|---|---|---|
| Shares Short | 3.05M | 1.35M |
| Short Ratio | 4.10 | 0.74 |
| Short % of Float | 0.04% | 0.15% |
| Average Daily Volume (10 Day) | 26,090,460 | 1,068,119 |
| Average Daily Volume (90 Day) | 9,430,330 | 1,840,761 |
| Shares Outstanding | 119.84M | 4.39M |
| Float Shares | 72.18M | 8.76M |
| % Held by Insiders | 0.19% | 0.00% |
| % Held by Institutions | 0.49% | 0.16% |
Dividend Analysis & Yield Comparison: Invivyd vs Tonix
| Metric | IVVD | TNXP |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |